Cargando…

Wild-type oestrogen receptor beta (ERβ1) mRNA and protein expression in Tamoxifen-treated post-menopausal breast cancers

This study has tested the hypothesis that comparison of protein and mRNA expression for ERα and ERβ1 by human breast cancers provides novel information relating to the clinical and pathological characteristics of human breast cancers. Expression of ERα and ERβ1 was identified in 167 invasive cancers...

Descripción completa

Detalles Bibliográficos
Autores principales:	O'Neill, P A, Davies, M P A, Shaaban, A M, Innes, H, Torevell, A, Sibson, D R, Foster, C S
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2004
Materias:	Molecular and Cellular Pathology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409946/ https://www.ncbi.nlm.nih.gov/pubmed/15477865 http://dx.doi.org/10.1038/sj.bjc.6602183

Ejemplares similares

The influence of tamoxifen treatment on the oestrogen receptor in metachronous contralateral breast cancer
por: Kaas, R, et al.
Publicado: (2003)

Expression of oestrogen receptor beta (ERβ1) protein in human breast cancer biopsies
por: Saunders, P T K, et al.
Publicado: (2002)

Increased risk of malignant progression in benign proliferating breast lesions defined by expression of heat shock protein 27
por: O'Neill, P A, et al.
Publicado: (2004)

Relationship of coregulator and oestrogen receptor isoform expression to de novo tamoxifen resistance in human breast cancer
por: Murphy, L C, et al.
Publicado: (2002)

Hypersensitive K303R oestrogen receptor-α variant not found in invasive carcinomas
por: Davies, Michael PA, et al.
Publicado: (2005)

Biological response to hormonal manipulation in oestrogen receptor positive ductal carcinoma in situ of the breast
por: Boland, G P, et al.
Publicado: (2003)

Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistance
por: Luo, L-Y, et al.
Publicado: (2002)

Tamoxifen induction of angiogenic factor expression in endometrium
por: Hague, S, et al.
Publicado: (2002)

Tumour necrosis factor and PI3-kinase control oestrogen receptor alpha protein level and its transrepression function
por: Bhat-Nakshatri, P, et al.
Publicado: (2004)

Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment
por: Michalides, R, et al.
Publicado: (2002)

Elevated protein kinase C alpha expression may be predictive of tamoxifen treatment failure
por: Tonetti, D A, et al.
Publicado: (2003)

Association of oestrogen receptor beta 2 (ERβ2/ERβcx) with outcome of adjuvant endocrine treatment for primary breast cancer – a retrospective study
por: Vinayagam, Raman, et al.
Publicado: (2007)

Steroid-free medium discloses oestrogenic effects of the bisphosphonate clodronate on breast cancer cells
por: Journe, F, et al.
Publicado: (2004)

Elevated expression of polymorphonuclear leukocyte elastase in breast cancer tissue is associated with tamoxifen failure in patients with advanced disease
por: Foekens, J A, et al.
Publicado: (2003)

MeCP2 and MBD2 expression in human neoplastic and non-neoplastic breast tissue and its association with oestrogen receptor status
por: Müller, H M, et al.
Publicado: (2003)

Vascular endothelial growth factor in node-positive breast cancer patients treated with adjuvant tamoxifen
por: Coradini, D, et al.
Publicado: (2003)

Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients
por: Stendahl, M, et al.
Publicado: (2004)

Identification of mRNAs differentially-expressed between benign and malignant breast tumour cells
por: Liu, D, et al.
Publicado: (2002)

Endometrial Surveillance in Tamoxifen and Letrozole Treated Breast Cancer Patients
por: AlZaabi, Adhari, et al.
Publicado: (2021)

Oestrogen receptor expression and the effects of oestrogen and tamoxifen on the growth of human ovarian carcinoma cell lines.
por: Langdon, S. P., et al.
Publicado: (1990)

Prognostic value of maspin mRNA expression in ERα-positive postmenopausal breast carcinomas
por: Bièche, I, et al.
Publicado: (2003)

Reduced PTEN expression in the pancreas overexpressing transforming growth factor-beta 1
por: Ebert, M P A, et al.
Publicado: (2002)

Functional analysis of the actin-binding protein, tropomyosin 1, in neuroblastoma
por: Yager, M L, et al.
Publicado: (2003)

Complete Regression of an 8-cm Desmoid Fibromatosis After Treatment With Tamoxifen
por: Suzuki, Ryosuke, et al.
Publicado: (2023)

Inverse relationship between ER-β and SRC-1 predicts outcome in endocrine-resistant breast cancer
por: Myers, E, et al.
Publicado: (2004)

Mutant, wild type, or overall p53 expression: freedom from clinical progression in tumours of astrocytic lineage
por: Pardo, F S, et al.
Publicado: (2004)

Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma
por: Sarela, A I, et al.
Publicado: (2002)

Differential SPARC mRNA expression in Barrett's oesophagus
por: Brabender, J, et al.
Publicado: (2003)

BASP1 interacts with oestrogen receptor α and modifies the tamoxifen response
por: Marsh, Lindsey A, et al.
Publicado: (2017)

Expression of the oestrogen regulated pNR-2 mRNA in human breast cancer: relation to oestrogen receptor mRNA levels and response to tamoxifen therapy.
por: Henry, J. A., et al.
Publicado: (1990)

Oestrogen Non-Genomic Signalling is Activated in Tamoxifen-Resistant Breast Cancer
por: Poulard, Coralie, et al.
Publicado: (2019)

Oestrogen-mediated cardioprotection following ischaemia and reperfusion is mimicked by an oestrogen receptor (ER)α agonist and unaffected by an ERβ antagonist
por: Jeanes, Helen L, et al.
Publicado: (2008)

Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple mRNA markers
por: Weigelt, B, et al.
Publicado: (2004)

Assessment of the quality and readability of online information on autopsy for the general public: a cross-sectional analysis
por: Hanley, Brian, et al.
Publicado: (2019)

Interaction between Ku80 protein and a widely used antibody to adenomatous polyposis coli
por: Roberts, G T, et al.
Publicado: (2003)

Upregulation of p16(INK4A) and Bax in p53 wild/p53-overexpressing crypts in ulcerative colitis-associated tumours
por: Yoshida, T, et al.
Publicado: (2004)

Oestrogen receptor β and neoadjuvant therapy with tamoxifen: prediction of response and effects of treatment
por: Miller, W R, et al.
Publicado: (2006)

Increased aquaporin 1 water channel expression inhuman brain tumours
por: Saadoun, S, et al.
Publicado: (2002)

An overview of menopausal oestrogen–progestin hormone therapy and breast cancer risk
por: Lee, S A, et al.
Publicado: (2005)

Menopausal oestrogens and breast cancer risk: an expanded case-control study.
por: Brinton, L. A., et al.
Publicado: (1986)

Cannot write session to /tmp/vufind_sessions/sess_80p2rvm5fjmiq83t4sia1792q4